chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Test: Covid, Result: Yes (positive); Test: Covid, Result: Yes (positive); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 65 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 19Nov2021 (Lot number: FJ8757) at the age of 65 years as dose 3 (booster), single, intramuscular, administered in arm right, administration date 31Mar2021 (Lot number: ER8734) as dose 2, single and intramuscular, administered in arm right, administration date 08Mar2021 12:00 (Lot number: EN6199) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Shingles" (unspecified if ongoing), notes: Shingles once; "Lyme disease" (unspecified if ongoing), notes: had a prescription for an antibiotic for Lyme disease once from 1956 to date that is it. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Test: Covid, Result: Yes (positive)". The patient underwent the following laboratory tests and procedures: blood test: unknown results, notes: let me know what my levels were. I believe he said 380; chest x-ray: no pneumonia; COVID test: yes, notes: Covid Result: Yes Positive; no, notes: Covid Result: No Negative.
A few days after receiving the second dose of the vaccine on the 20th of May. I began to have random chest/heart pressure when breathing out/ swallowing food or drinks. I began to rest and took ibuprofen (Motrin) to relive my side effects. I soon began to feel more or less the same symptoms  on the 26th and 27th of May. On the 28th I woke up to the sides of my stomach hurting, but went away once I ate breakfast. Days go by and I felt my symptoms going down. Around May 30th to June 1st, sometime in between I felt that my symptoms had been relived, As of June 6th, the day I am reporting this event I have not felt what I felt during those days.
Prior to and during vaccine administration, patient was crying and hyperventilating.  After vaccines administered, nursing notified that she was not acting appropriately.  She was sleepy, difficult to arouse. She was starting off, not responding to questions and difficult to keep awake.  Later complaining of chest pain, headache, flank pain, difficulty raising her arm and continues to be slow to answer questioning, not oriented to time or place. Altered mental status of 45 minutes in duration.  Glucose normal, given juice and crackers.  Tylenol for pain.  Admitted to the hospital with neurology consult, and with EKG.
Patient was at the doctor's office for a physical at 11am and Blood Pressure was 120/70 with a 60 pulse. About 2 hours after receiving the vaccine, the arm became very sore. Patient has been taking ½ dose of Losartan for about 5-6 years to maintain normal levels. However, the blood pressure was at 150/90 with an 85 pulse. The doctor's office was closed already so patient called doctor office the next morning. Patient directed to start taking full dose of Losartan. Patient reports arm hurt for about 6 days. On 3/6 patient had follow-up appointment with doctor for another matter. Doctor mentioned that it is possible that problems were vaccine related and recommended to continue taking full dose of medication.  It has been 1 month and even with full dose of medication the systolic blood pressure still is high--130-137. Patient takes BP readings about 3 times a day. Patient has follow-up appointment with doctor in mid-May. Wife received the same vaccine on the same day and her arm was sore for a couple of days.
Patient with a known anaphylactic allergy to peanuts and allergic to PCN received first dose of Moderna. Approximately 15 minutes post vaccine, she reported itching to her right arm. She has an EpiPen but did not deploy it. She was treated by paramedics with 50 mg Benadryl IM left deltoid. She reported resolution of symptoms, denied swollen lips, throat, or difficulty breathing. She declined transport, stating she will follow up with her allergist.
Pt said itching started 10/3/13 after receiving the vaccine since then she has had dermatitis, gland problems, lesions, and eye infections. She said she has seen 5 doctors and they feel it was a reaction to the flu shot pt did not tell us until 12/30/13.
Feeling a little tired; Fogginess; Dizziness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Fogginess), DIZZINESS (Dizziness), NAUSEA (Nausea) and FATIGUE (Feeling a little tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced FEELING ABNORMAL (Fogginess), DIZZINESS (Dizziness) and NAUSEA (Nausea). On 29-Mar-2021, the patient experienced FATIGUE (Feeling a little tired). On 30-Mar-2021, FEELING ABNORMAL (Fogginess), DIZZINESS (Dizziness), NAUSEA (Nausea) and FATIGUE (Feeling a little tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details not provided
This spontaneous report as received from a nurse refers to 20 unspecified patients of unknown age and demography. No concurrent conditions and medical history were reported. On an unknown date approximately in 2015 (also reported as between 29-APR-2015 and 29-JUN-2015) the patient was vaccinated with (Merck) VARIVAX (lot: K007784; expiration date 28-MAY-2016 and lot: K010439; expiration: 22-JUL-2016) subcutaneously which was improperly exposed to minus 12.3 degrees centigrade for a cumulative of 17 hours (incorrect product storage). On unspecified dates from 05-MAY-2015 to 29-JUN-2015, 20 patients each received one of the improperly exposed vaccines listed above. It was unspecified which patient received which lot. It was also unspecified exactly how long each lot was actually improperly stored before being administered to each patient. No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint reported. The action taken and outcome of the events was unknown. This is one of the two reports from the same source. Additional information has been requested.
Fever 102 for 5 days. Red, swelling, tender area on site of administration, warmth area about 5cmx5cm. Oral antibiotics were used (Keflex).
severe joint pain and fatigue - short lived (24hrs or less) early menstrual cycle onset - 9 days early, much more painful and much heavier bleeding than usual. Very unusual for personal cycle and concerning. Will seek medical care if heavy bleeding continues for much longer. Fatigue has set in and causing disruption to concentration and ability to perform work.
laid up for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of BEDRIDDEN (laid up for 3 days) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer and Aneurysm.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced BEDRIDDEN (laid up for 3 days). At the time of the report, BEDRIDDEN (laid up for 3 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up information received on 07-JUN-2021 contains non-significant information- Contact information updated
This spontaneous report was received from a female patient of unknown age (who was also a pharmacist) and refers to herself. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 12-APR-2016, the patient was subcutaneously vaccinated with ZOSTAVAX (dose, lot # and expiration date were not reported). On 12-APR-2016 (also reported as 12-APR-2106), the patient experienced redness and swelling "about the size of her palm" around the injection site. This area was also warm to the touch. The patient did not seek medical attention. No treatment was given for the adverse events. The outcome of the events was reported as not recovered, at the time of the report, the area was still red, swollen and warm to the touch. The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Approximately 10 minutes after vaccinations given nurse was called to waiting room where child was found to be coughing and audibly wheezing.  Child taken to exam room and Benadryl 12.5 mg given po.  Color pink and child irritable staff but appropriate with parent.  Child and mother waited 20 minutes in office and then instructed to go to the emergency room.  Child continued to have audible wheezing. Upon arrival to ER back of left arm was swollen, red and hot.  ER physician informed mother that the shot given in this arm should not be repeated.
Vaccine recipient received vaccine on 12/17/2020. Reported that they felt tired the next day. Three days after receiving the vaccine, reported to develop headache and neck/should pain. This was still bothering the vaccine recipient. Directed to follow-up with occupation health.
Began with a rash to the right forearm, followed by swelling about the size of an egg, followed by blurry vision and ringing of the ears.  About two to three hours later, severe coughing with a feeling like a lump in the throat and difficulty breathing occurred.  Was on the way to workman's comp doctor, then had to be transported via AMR to hospital ER for treatment.  Ongoing ringing of the ears leading to severe headaches.
right eyelid is swollen, painful, and sensitive; right eyelid is swollen, painful, and sensitive; right eyelid is swollen, painful, and sensitive; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (right eyelid is swollen, painful, and sensitive), EYELID PAIN (right eyelid is swollen, painful, and sensitive) and EYELID IRRITATION (right eyelid is swollen, painful, and sensitive) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING OF EYELID (right eyelid is swollen, painful, and sensitive), EYELID PAIN (right eyelid is swollen, painful, and sensitive) and EYELID IRRITATION (right eyelid is swollen, painful, and sensitive). At the time of the report, SWELLING OF EYELID (right eyelid is swollen, painful, and sensitive), EYELID PAIN (right eyelid is swollen, painful, and sensitive) and EYELID IRRITATION (right eyelid is swollen, painful, and sensitive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient used to take a blood thinner, but he stopped using it two days before taking his first dose No treatment medications were reported
Mild case of nausea (lasted 4 hours), body aches (lasted 10 hours)
upset stomach; sore arm; This is a spontaneous report received from a non-contactable consumer (Patient's wife). A male patient of unspecified age received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose unspecified via an unspecified route of administration on unknown date (Batch/Lot number was not reported) as SINGLE dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had sore arm and upset stomach. The outcome for events were unknown.   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Intense (L) shoulder pain at time of vac. - cont to this day. TX P.T. and over counter med.
Breakthrough case admission after 2 vaccines Pfizer 4/20/21 Lot# EM9810; Pfizer 5/11/21 Lot# EM9810
Transient ischemic attack (TIA) - Mini Stroke; Dose Number: 1, Date: Jan2022 / Dose Number: 2, Date: Aug2022; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Aug2022 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, product=COVID 19,, brand=Pfizer-BioNTech COVID-19 vaccine,, lot unknown reason=Not available/provided to reporter at the time of report completion,, administration date=Jan2022,, administration time=01:15 PM), administration date: Jan2022, for COVID-19 Immunization. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset Aug2022, outcome "unknown", described as "Dose Number: 1, Date: Jan2022 / Dose Number: 2, Date: Aug2022"; TRANSIENT ISCHAEMIC ATTACK (hospitalization, disability, medically significant) with onset Nov2022, outcome "not recovered", described as "Transient ischemic attack (TIA) - Mini Stroke". The patient was hospitalized for transient ischaemic attack (hospitalization duration: 2 day(s)). The event "transient ischemic attack (tia) - mini stroke" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of transient ischaemic attack treated with blood thinner and physical therapy.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine brand: Pfizer/BioNTech, product: COVID 19 Treatment; Vaccine brand: Pfizer/BioNTech, product: COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient received BNT162b2 (BNT162B2), on 20Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 65 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "allergy" (unspecified if ongoing). Concomitant medication(s) included: THYROID. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 29May2022, outcome "not recovered" and all described as "Vaccine brand: Pfizer/BioNTech, product: COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: Other medication product the patient took in 2 weeks was Thyroid and allergy. The patient took COVID 19 treatment with Paxlovid (Treatment start date: 20May2022, Treatment stop date: 24May2022). The patient experienced Paxlovid rebound symptoms day 10, rapid antigen test positive on 29May2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
12FEB93 febrile seizures; pt seen 6FEB93 @ hosp given Amoxil for URI; seen 12FEB @ clinic for rt OM; started on Pediazole; later that evening fever to 103 pt began sz; seen in ER;
I had the shot and my only symptom was bruising at the injection site and sore arm.  After a few days my arm no longer hurt, but the bruise remained.  6 days after my injection, I experienced mild itching at the injection site.  Day 7 I noticed my arm was red, swollen, warm to touch, and itchy.  Day 8, my arm continued to swell and the area that was red was larger and very warm to touch at the injection   site.  My arm was also beginning to feel heavy.  I contacted and saw my pcp on day 8 and was told to take an antihistamine.  I took clarity and my symptoms are starting to improve.
headache; nausea; really tired; had fever for a little bit; This is a spontaneous report from a contactable consumer (patient) reported for herself.  A 20-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route at left arm on 09Apr2021 at 10:00 am (lot number: EN6202) (age at vaccination 20-year-old) as dose 2, single for COVID-19 immunisation. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via unknown route at left arm on 22Mar2021 at 09:00 am (lot number: EN6208) as dose 1, single for COVID-19 immunisation which was a defective dose. she did not get symptoms after the 1st dose of the vaccine. The patient medical history was reported as none and concomitant medication was not reported. History of all previous immunization with the Pfizer vaccine considered as suspect and additional Vaccines Administered on Same Date of the Pfizer Suspect: None. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had testing for COVID19 regularly and has not had covid19 and every test she has taken is negative for covid19. The patient had a headache, nausea, and was really tired and had fever for a little bit; states the symptoms started the night of 09Apr2021. The adverse events did not required to visit ER or MD office. She has not required treatment for the reported events. 24 hours later after the symptoms started and resolved the night of 10Apr2021.  No follow-up attempts are needed. No further information is expected.
Hives on ankles and wrists.  Treated with hydrocortisone 1% cream
Information has been received from a consumer referring to his wife, a 40 year old female patient with lupus and allergy to gabapentin and compazine. The patient has a history of migraine headaches. On 19-SEP-2015 the patient was vaccinated with a dose of ZOSTAVAX (lot # not reported, 0.65 ml/one time injection, subcutaneously in the back of the left arm) (recommended by her rheumatologist, which was other than indicated in the Prescribing Information (off label use). There was no concomitant medication. On 20-SEP-2015 the patient experienced headaches for three days following the injection of ZOSTAVAX and was treated with TYLENOL. An unspecified number of days after receiving the ZOSTAVAX vaccine injection, inui September 2015 the patient noticed a series of bumps on the right side of her body near her hip and on her right forearm. No lab diagnostics studies were performed. The patient did not seek medical attention for the adverse events of ZOSTAVAX, but would contact her healthcare professional (HCP). Outcome of the event "headaches" was reported as recovered on 22-SEP-2015 (estimated per three days duration). Outcome of the event "bumps on the right side of her body near her hip and on her right forearm" was reported as not recovered. Outcome of the event "off label use" was unknown. The causality was not provided. Additional information has been requested.
Raised area at the injection site with pruritus and slight warmth to touch. No drainage, no fever or chills or temperature. Noticed it 6 days after injection.
itchiness all over her back and body, itchiness on her spine area; uncomfortable sensation of skin; Itchiness started from injection site; feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness all over her back and body, itchiness on her spine area), SKIN DISCOMFORT (uncomfortable sensation of skin), VACCINATION SITE PRURITUS (Itchiness started from injection site) and FATIGUE (feeling tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PRURITUS (itchiness all over her back and body, itchiness on her spine area), SKIN DISCOMFORT (uncomfortable sensation of skin), VACCINATION SITE PRURITUS (Itchiness started from injection site) and FATIGUE (feeling tired). At the time of the report, PRURITUS (itchiness all over her back and body, itchiness on her spine area), SKIN DISCOMFORT (uncomfortable sensation of skin), VACCINATION SITE PRURITUS (Itchiness started from injection site) and FATIGUE (feeling tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old male patient received BNT162b2 (BNT162B2), on 27Feb2021 as dose 1, single (Lot number: EN6203), in left arm, on 20Mar2021 as dose 2, single (Lot number: EN6206), in left arm and on 08Oct2021 at 09:00 as dose 3 (booster), single (Lot number: FF2587) at the age of 29 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Addition information: Start date of treatment for COVID-19 was 01Jul2022. Stop date of treatment for COVID-19 was 06Jul2022.  No follow-up attempts are possible. No further information is expected.
approx 1hr p/vax pt was a little cranky & had a temp of 101 according to mom, gave APAP, no other problems noted;
I had a fever of 102, sinus congestion, sore throat, mild frontal headache, fatigue, body aches, and loss my smell. I tested positive for COVID-19 at home. I spoke to my doctor, and he did not prescribe my anything. I still have sinus congestion and loss of smell.
In February after receiving the vaccine I broke out in a rash on my ankles, chest, neck, cheeks (occasionally), hands and wrist. I made an appointment to see my doctor who gave me an appointment to my doctor who gave me a steroid injection. It cleared up for a couple of months but did come back. I have used both the steroid cream and ointment, but it does not go away completely. I have recently had a biopsy done on the rash and awaiting the results the I will get tomorrow (01/26/23). We are hoping to find what is causing the rash and a method to get rid of it for good.
Rec'd hep A and MMR vaccine on 4/24/13. On 5/8/13 called us to c/o fading rash and (L) knee swelling. Stated knee is 2x bigger than (R) knee and that his is unable to climb stairs. Was instructed to see M.D. 5/9/13 P.C. to client. He did not go to M.D. and reports that he is all better today. Is scheduled for 2nd MMR. Told to check with PHD if he has concerns about receiving 2nd MMR. 5/8/13 was a rainy day, but pt states no hx. arthritis.